Journal Mobile Options

Vol. 9, No. 4, 1996

Issue release date: 1996

Published under Skin Pharmacology
Select / Unselect all

Cytochrome P-450 and Drug Development for Skin Diseases

Ahmad N. · Agarwal R. · Mukhtar H.
Skin Pharmacol 1996;9:231–241 (DOI:10.1159/000211420)
Original Research Article

Effect of Imidazole Derivatives on Cytochrome P-450 Enzyme Activities in a Reconstructed Human Epidermis

Cotovio J. · Roguet R. · Pion F.X. · Rougier A. · Leclaire J.
Skin Pharmacol 1996;9:242–249 (DOI:10.1159/000211421)

Effect of μ, δ and κ Opioid Receptor Agonists on a Reactive Oxygen Species Mediated Model of Skin Inflammation

Earl J.R. · Grootveld M.C. · Blake D.R. · Morris C.J.
Skin Pharmacol 1996;9:250–258 (DOI:10.1159/000211422)

In vitro Study of Percutaneous Absorption, Cutaneous Bioavailability and Bioequivalence of Zinc and Copper from Five Topical Formulations

Pirot F. · Millet J. · Kalia Y.N. · Humbert P.
Skin Pharmacol 1996;9:259–269 (DOI:10.1159/000211423)

Influence of Ion Pairing on ex vivo Penetration of Erythromycin into Sebaceous Follicles

Matschiner S. · Neubert R. · Wohlrab W. · Matschiner F.
Skin Pharmacol 1996;9:270–273 (DOI:10.1159/000211424)

Effects of Freezing and Azide Treatment of in vitro Human Skin on the Flux and Metabolism of 8-Methoxypsoralen

Shaikh N.A. · Ademola J.I. · Maibach H.I.
Skin Pharmacol 1996;9:274–280 (DOI:10.1159/000211425)

The Effect of Cyclosporin A and FK 506 on the cAMP Content in Psoriatic Keratinocytes

Ockenfels H.M. · Nussbaum G. · Schneck B. · Wagner S.N. · Haen E. · Goos M.
Skin Pharmacol 1996;9:281–288 (DOI:10.1159/000211426)